For the Inventor, By the Inventor

Enter assignee name

Eden Prairie, MN, United States of America

Metavention, Inc.

Calculating rank

USPTO Granted Patents = 25

EPO Patents = 3

Forward Citations = 613

Loading Chart...

Loading Chart...

6 inventors (with patents filed for the assignee):

Bobak Robert Azamian (25 out of 39 patents)

Scott Bradley Vafai (24 out of 30 patents)

Jonathan A Coe (21 out of 60 patents)

4. Anthony Ciro Vrba (1 out of 53 patents)

5. James G Hansen (1 out of 20 patents)

6. Scott Raymond Smith (1 out of 79 patents)

7. Mark Wilson Ian Webster (1 patent)

8. Kelly Justin McCrystle (17 patents)

9. Michael David Perry (0 patent)

10. Eric Robert Reuland (0 patent)

11. Victor Kelvin Sun (0 patent)

12. Kathryn Elizabeth Empanger (0 patent)

13. Kenneth J Malomo (0 patent)

14. Rossana Motta (0 patent)

15. Kevin Robert Hykes (0 patent)

Core Competencies:

Neuromodulation

Metabolic Conditions

Hepatic Plexus

Glucose Levels

Therapeutic Devices

Balloon Catheter

Nerve Modulation

Fatty Liver Disease

Energy Delivery

Chemical Agents

Thermal Induction

Denervation

25 patents: Sort by Forward Citations

1. 10856926 - Neuromodulation for metabolic conditions or syndromes (2020-12-08),

2. 10617460 - Neuromodulation for metabolic conditions or syndromes (2020-04-14),

3. 10543034 - Modulation of nerves innervating the liver (2020-01-28),

4. 10524859 - Therapeutic tissue modulation devices and methods (2020-01-07),

5. 10070911 - Neuromodulation methods to alter glucose levels (2018-09-11),

6. 10064674 - Methods of modulating nerves of the hepatic plexus (2018-09-04),

7. 9999461 - Therapeutic denervation of nerves surrounding a hepatic vessel (2018-06-19),

8. 9265575 - Balloon catheter neuromodulation systems (2016-02-23),

9. 9149329 - Glucose alteration methods (2015-10-06),

10. 9114124 - Modulation of nerves innervating the liver (2015-08-25),

11. 9114123 - Hepatic neuromodulation using fluids or chemical agents (2015-08-25),

12. 9089542 - Hepatic neuromodulation using microwave energy (2015-07-28),

13. 9089541 - Gastroduodenal artery neuromodulation (2015-07-28),

14. 9060784 - Hepatic denervation systems (2015-06-23),

15. 9033969 - Nerve modulation to treat diabetes (2015-05-19),

Company Overview

Metavention, Inc. is a medical technology company based in Eden Prairie, Minnesota, specializing in innovative solutions for metabolic diseases. The organization focuses on developing advanced therapeutic devices aimed at improving patient outcomes in conditions such as diabetes and obesity. By leveraging cutting-edge research and technology, Metavention aims to transform the management of metabolic disorders, enhancing the quality of life for patients through effective and minimally invasive interventions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

25 Patents

#33 in Eden Prairie, MN

#400 in Minnesota

#13,370 in US

#25,730 in the World

Eden Prairie, MN, United States of America

Metavention, Inc.

Forward Citations = 613

6 inventors:

Bobak Robert Azamian (25 out of 39 patents)

Scott Bradley Vafai (24 out of 30 patents)

Jonathan A Coe (21 out of 60 patents)

4. Anthony Ciro Vrba (1 out of 53 patents)

5. James G Hansen (1 out of 20 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Metavention, Inc.. Retrieved from https://idiyas.com/company/metavention

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…